Genetic association of Fc receptor-like 3 polymorphisms with susceptibility to primary biliary cirrhosis: Ethnic comparative study in Japanese and Italian patients

Tissue Antigens

Volumn 77, Issue 3, 2011, Pages 239-243

  Tanaka, A ^a   Ohira, H ^b   Kikuchi, K ^c   Nezu, S ^d   Shibuya, A ^e   Bianchi, I ^f,g   Podda, M ^f,g   Invernizzi, P ^f,h   Takikawa, H ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^c TEIKYO UNIVERSITY MIZONOKUCHI HOSPITAL   (Japan)

^d KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^g UNIVERSITY OF MILAN   (Italy)

^h UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autoimmune disease; Genetic polymorphism; Single nucleotide polymorphism

Indexed keywords

FC RECEPTOR LIKE 3; MEMBRANE PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; ETHNIC DIFFERENCE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HUMAN; ITALY; JAPANESE; MAJOR CLINICAL STUDY; MALE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; AUTOIMMUNE DISEASES; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; ITALY; LIVER CIRRHOSIS, BILIARY; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, IMMUNOLOGIC;

EID: 79551678271     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2010.01600.x     Document Type: Article

References (34)

1. Kaplan M, Gershwin M. Primary biliary cirrhosis. New Engl J Med 2005: 353: 1261-73.
2. Lindor KD, Gershwin ME, Poupon R, Kaplan M, Bergasa NV, Heathcote EJ. Primary biliary cirrhosis. Hepatology 2009: 50: 291-308.
3. Gershwin ME, Mackay IR. The causes of primary biliary cirrhosis: convenient and inconvenient truths. Hepatology 2008: 47: 737-45.
4. Invernizzi P, Selmi C, Mackay I, Podda M, Gershwin M. From bases to basis: linking genetics to causation in primary biliary cirrhosis. Clin Gastroenterol Hepatol 2005: 3: 401-10.
5. Hirschfield GM, Liu X, Han Y et al. Variants at IRF5-TNPO3, 17q12-21 and MMEL1 are associated with primary biliary cirrhosis. Nat Genet 2010: 42: 655-7.
6. Hirschfield GM, Liu X, Xu C et al. Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants. N Engl J Med 2009: 360: 2544-55.
7. Liu X, Invernizzi P, Lu Y et al. Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis. Nat Genet 2010: 42: 658-60.
8. Davis RS, Wang YH, Kubagawa H, Cooper MD. Identification of a family of Fc receptor homologs with preferential B cell expression. Proc Natl Acad Sci U S A 2001: 98: 9772-7.
9. Miller I, Hatzivassiliou G, Cattoretti G, Mendelsohn C, Dalla-Favera R. IRTAs: a new family of immunoglobulinlike receptors differentially expressed in B cells. Blood 2002: 99: 2662-9.
10. Ikari K, Momohara S, Nakamura T et al. Supportive evidence for a genetic association of the FCRL3 promoter polymorphism with rheumatoid arthritis. Ann Rheum Dis 2006: 65: 671-3.
11. Kochi Y, Yamada R, Suzuki A et al. A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities. Nat Genet 2005: 37: 478-85.
12. Umemura T, Ota M, Hamano H, Katsuyama Y, Kiyosawa K, Kawa S. Genetic association of Fc receptor-like 3 polymorphisms with autoimmune pancreatitis in Japanese patients. Gut 2006: 55: 1367-8.
13. Kochi Y, Myouzen K, Yamada R et al. FCRL3, an autoimmune susceptibility gene, has inhibitory potential on B-cell receptor-mediated signaling. J Immunol 2009: 183: 5502-10.
14. Hu X, Chang M, Saiki RK et al. The functional -169T->C single-nucleotide polymorphism in FCRL3 is not associated with rheumatoid arthritis in white North Americans. Arthritis Rheum 2006: 54: 1022-5.
15. Martinez A, Sanchez E, Valdivia A et al. Epistatic interaction between FCRL3 and NFkappaB1 genes in Spanish patients with rheumatoid arthritis. Ann Rheum Dis 2006: 65: 1188-91.
16. Newman WG, Zhang Q, Liu X et al. Rheumatoid arthritis association with the FCRL3 -169C polymorphism is restricted to PTPN22 1858T-homozygous individuals in a Canadian population. Arthritis Rheum 2006: 54: 3820-7.
17. Sanchez E, Callejas JL, Sabio JM et al. Polymorphisms of the FCRL3 gene in a Spanish population of systemic lupus erythematosus patients. Rheumatology (Oxford) 2006: 45: 1044-6.
18. Thabet MM, Wesoly J, Slagboom PE, Toes RE, Huizinga TW. FCRL3 promoter 169 CC homozygosity is associated with susceptibility to rheumatoid arthritis in Dutch Caucasians. Ann Rheum Dis 2007: 66: 803-6.
19. Lee YH, Woo JH, Choi SJ, Ji JD, Song GG. Fc receptor-like 3 -169 C/T polymorphism and RA susceptibility: a meta-analysis. Rheumatol Int 2010: 30: 947-53.
20. Mao C, Pan H, Chen Q, Wang X, Ye D, Qiu L. Association between Fc receptor-like 3 C169T polymorphism and risk of systemic lupus erythematosus: a meta-analysis. Mol Biol Rep 2010: 37: 191-6.
21. Owen CJ, Kelly H, Eden JA, Merriman ME, Pearce SH, Merriman TR. Analysis of the Fc receptor-like-3 (FCRL3) locus in Caucasians with autoimmune disorders suggests a complex pattern of disease association. J Clin Endocrinol Metab 2007: 92: 1106-11.
22. Simmonds MJ, Heward JM, Carr-Smith J, Foxall H, Franklyn JA, Gough SC. Contribution of single nucleotide polymorphisms within FCRL3 and MAP3K7IP2 to the pathogenesis of Graves' disease. J Clin Endocrinol Metab 2006: 91: 1056-61.
23. Burton PR, Clayton DG, Cardon LR et al. Association scan of 14, 500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet 2007: 39: 1329-37.
24. Kochi Y, Suzuki A, Yamada R, Yamamoto K. Genetics of rheumatoid arthritis: underlying evidence of ethnic differences. J Autoimmun 2009: 32: 158-62.
25. Heathcote E. Primary biliary cirrhosis. In: Schiff E, Sorrell M, Maddrey W, eds. Schiff's Diseases of the Liver. Philadelphia Lippincott Williams & Wilkins, 2003, 673-84.
26. Matsumura M, Hikiba Y, Ogura K et al. Rapid detection of mutations in the 23S rRNA gene of Helicobacter pylori that confers resistance to clarithromycin treatment to the bacterium. J Clin Microbiol 2001: 39: 691-5.
27. Moteki S, Leung PS, Coppel RL et al. Use of a designer triple expression hybrid clone for three different lipoyl domain for the detection of antimitochondrial autoantibodies. Hepatology 1996: 24: 97-103.
28. Gibson AW, Li FJ, Wu J et al. The FCRL3 -169CT promoter single-nucleotide polymorphism, which is associated with systemic lupus erythematosus in a Japanese population, predicts expression of receptor protein on CD19+B cells. Arthritis Rheum 2009: 60: 3510-2.
29. Swainson LA, Mold JE, Bajpai UD, McCune JM. Expression of the autoimmune susceptibility gene FcRL3 on human regulatory T cells is associated with dysfunction and high levels of programmed cell death-1. J Immunol 2010: 184: 3639-47.
30. Alarcon GS, Schrohenloher RE, Bartolucci AA, Ward JR, Williams HJ, Koopman WJ. Suppression of rheumatoid factor production by methotrexate in patients with rheumatoid arthritis. Evidence for differential influences of therapy and clinical status on IgM and IgA rheumatoid factor expression. Arthritis Rheum 1990: 33: 1156-61.
31. van Venrooij WJ, van Beers JJ, Pruijn GJ. Anti-CCP antibody, a marker for the early detection of rheumatoid arthritis. Ann N Y Acad Sci 2008: 1143: 268-85.
32. Invernizzi P, Crosignani A, Battezzati P et al. Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and -negative primary biliary cirrhosis. Hepatology 1997: 25: 1090-5.
33. Mendes F, Lindor KD. Antimitochondrial antibody-negative primary biliary cirrhosis. Gastroenterol Clin North Am 2008: 37: 479-84, viii.
34. Stahl EA, Raychaudhuri S, Remmers EF et al. Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat Genet 2010: 42: 508-14.